← Back to Search

DHRT Training Devices for Central Venous Catheter Placement Skills

N/A
Recruiting
Led By Scarlett R Miller, Ph.D.
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient undergoing central venous catheterization
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-intervention), post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether two devices used to train medical residents improve the residents' ability to place central venous catheters, and whether this results in fewer complications for patients.

Who is the study for?
This trial is for medical residents learning to insert central venous catheters (CVCs) and patients undergoing CVC procedures. Residents must be in their first year at Hershey Medical Center or Cedars-Sinai Medical Center, and patients must be scheduled for a CVC insertion.
What is being tested?
The study tests two training devices: the Dynamic Haptic Robotic Trainer (DHRT) and an advanced version, DHRT+. It measures how well these tools help residents learn to perform CVC insertions compared to current training methods.
What are the potential side effects?
There are no direct side effects from using the DHRT or DHRT+ as they are non-invasive training tools. However, there's always a risk of infection or complications associated with actual CVC insertion procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am getting a central venous catheter placed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention), post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention), post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Central Line Related Complications due to new Resident Central Line Training Procedures
Change in Central Line Related Infections due to new Resident Central Line Training Procedures

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Residents to receive Dynamic Haptic Robotic TrainingExperimental Treatment1 Intervention
Group II: Residents to receive Advanced Dynamic Haptic Robotic TrainingExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
511 Previous Clinical Trials
2,870,235 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,944 Previous Clinical Trials
47,799,207 Total Patients Enrolled
Scarlett R Miller, Ph.D.Principal InvestigatorPenn State University
Jason Z. Moore, Ph.D.Principal InvestigatorPenn State University

Media Library

Advanced Dynamic Haptic Robotic Trainer (DHRT+) Clinical Trial Eligibility Overview. Trial Name: NCT04541446 — N/A
Central Line Bloodstream Infection Research Study Groups: Residents to receive Advanced Dynamic Haptic Robotic Training, Residents to receive Dynamic Haptic Robotic Training
Central Line Bloodstream Infection Clinical Trial 2023: Advanced Dynamic Haptic Robotic Trainer (DHRT+) Highlights & Side Effects. Trial Name: NCT04541446 — N/A
Advanced Dynamic Haptic Robotic Trainer (DHRT+) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04541446 — N/A
~117 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top